 |
PDBsum entry 1mcs
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immunoglobulin
|
PDB id
|
|
|
|
1mcs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Proteins
16:246-267
(1993)
|
|
PubMed id:
|
|
|
|
|
| |
|
Principles and pitfalls in designing site-directed peptide ligands.
|
|
A.B.Edmundson,
D.L.Harris,
Z.C.Fan,
L.W.Guddat,
B.T.Schley,
B.L.Hanson,
G.Tribbick,
H.M.Geysen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
An immunoglobulin light chain dimer with a large generic binding cavity was used
as a host molecule for designing a series of peptide guest ligands. In a
screening procedure peptides coupled to solid supports were systematically
tested for binding activity by enzyme linked immunosorbent assays (ELISA). Key
members of the binding series were synthesized in milligram quantities and
diffused into crystals of the host molecule for X-ray analyses. These peptides
were incrementally increased in size and affinity until they nearly filled the
cavity. Progressive changes in binding patterns were mapped by comparisons of
crystallographically refined structures of 14 peptide-protein complexes at 2.7 A
resolution. These comparisons led to guidelines for ligand design and also
suggested ways to modify previously established binding patterns. By
manipulating equilibria involving histidine, for example, it was possible to
abolish one important intramolecular interaction of the bound ligand and
substitute another. These events triggered a change in conformation of the
ligand from a compact to an extended form and a comprehensive change in the mode
of binding to the protein. In dipeptides of histidine and proline, protonation
of both imidazolium nitrogen atoms was used to program an end-to-end reversal of
the direction in which the ligand was inserted into the binding cavity. Peptides
cocrystallized with proteins produced complexes somewhat different in structure
from those in which ligands were diffused into preexisting crystals. In such a
large and malleable cavity, space utilization was thus different when a ligand
was introduced before the imposition of crystal packing restraints.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.M.Yang,
and
C.C.Chen
(2004).
GEMDOCK: a generic evolutionary method for molecular docking.
|
| |
Proteins,
55,
288-304.
|
 |
|
|
|
|
 |
J.B.Mitchell,
and
J.Smith
(2003).
D-amino acid residues in peptides and proteins.
|
| |
Proteins,
50,
563-571.
|
 |
|
|
|
|
 |
A.B.Edmundson,
and
A.B.Edmundson
(2002).
Reminiscences: joyous moments along the road from here to there and back again.
|
| |
J Mol Recognit,
15,
227-239.
|
 |
|
|
|
|
 |
E.Yuriev,
and
P.A.Ramsland
(2002).
Mcg light chain dimer as a model system for ligand design: a docking study.
|
| |
J Mol Recognit,
15,
331-340.
|
 |
|
|
|
|
 |
P.C.Bourne,
P.A.Ramsland,
L.Shan,
Z.C.Fan,
C.R.DeWitt,
B.B.Shultz,
S.S.Terzyan,
C.R.Moomaw,
C.A.Slaughter,
L.W.Guddat,
and
A.B.Edmundson
(2002).
Three-dimensional structure of an immunoglobulin light-chain dimer with amyloidogenic properties.
|
| |
Acta Crystallogr D Biol Crystallogr,
58,
815-823.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.B.Edmundson,
G.Tribbick,
S.Plompen,
H.M.Geysen,
E.Yuriev,
and
P.A.Ramsland
(2001).
Binding of synthetic peptides by a human monoclonal IgM with an unusual combining site structure.
|
| |
J Mol Recognit,
14,
229-238.
|
 |
|
|
|
|
 |
E.Yuriev,
P.A.Ramsland,
and
A.B.Edmundson
(2001).
Docking of combinatorial peptide libraries into a broadly cross-reactive human IgM.
|
| |
J Mol Recognit,
14,
172-184.
|
 |
|
|
|
|
 |
P.A.Ramsland,
B.F.Movafagh,
M.Reichlin,
and
A.B.Edmundson
(1999).
Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
|
| |
J Mol Recognit,
12,
249-257.
|
 |
|
|
|
|
 |
Z.C.Fan,
L.Shan,
B.Z.Goldsteen,
L.W.Guddat,
A.Thakur,
N.F.Landolfi,
M.S.Co,
M.Vasquez,
C.Queen,
P.A.Ramsland,
and
A.B.Edmundson
(1999).
Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
|
| |
J Mol Recognit,
12,
19-32.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.B.Edmundson,
and
C.V.Manion
(1998).
Treatment of osteoarthritis with aspartame.
|
| |
Clin Pharmacol Ther,
63,
580-593.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |